Dr. Terry D. Box, M.D.
Gastroenterology (Gastroenterology Physician)
At a glance
- In the NPI registry since
- 2006
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
UT license 163791-1205 -
Transplant Hepatology Physician
UT license 163791-1205
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Payments from drug and device companies
In 2025, 5 companies reported 80 payments worth $74,046 in total to this clinician.
| Gilead Sciences, Inc. | $46,196 |
|---|---|
| AbbVie Inc. | $19,511 |
| Intercept Pharmaceuticals, Inc. | $8,258 |
| GlaxoSmithKline, LLC. | $57.09 |
| Madrigal Pharmaceuticals | $24.21 |
| Compensation for services other than consulting (speaking, faculty) | $51,115 |
|---|---|
| Consulting Fee | $10,960 |
| Travel and Lodging | $9,674 |
| Food and Beverage | $2,296 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Gilead Sciences, Inc. Jan 16, 2025 | Compensation for services other than consulting (speaking, faculty) Livdelzi · INFLAM Company’s description;4112769;AHM;10042045 | $6,440 |
| Gilead Sciences, Inc. Feb 28, 2025 | Compensation for services other than consulting (speaking, faculty) Livdelzi · INFLAM Company’s description;4124425;AHM;10042045 | $6,440 |
| Intercept Pharmaceuticals, Inc. Mar 29, 2025 | Consulting Fee OCALIVA · Hepatology / Gastroenterology | $6,200 |
| Gilead Sciences, Inc. Apr 1, 2025 | Compensation for services other than consulting (speaking, faculty) Livdelzi · INFLAM Company’s description;4119486;AHM;10042045 | $4,930 |
| Gilead Sciences, Inc. Jun 10, 2025 | Compensation for services other than consulting (speaking, faculty) Epclusa · HCV Company’s description;4121003;AHM;10042045 | $4,930 |
| Gilead Sciences, Inc. Feb 10, 2025 | Consulting Fee Epclusa · HCV Company’s description;4146792;VEM US;10042045 | $4,760 |
| AbbVie Inc. Jul 30, 2025 | Compensation for services other than consulting (speaking, faculty) MAVYRET · VIROLOGY | $4,600 |
| Gilead Sciences, Inc. Jan 16, 2025 | Compensation for services other than consulting (speaking, faculty) Epclusa · HCV Company’s description;4128075;AHM;10042045 | $3,790 |
| Gilead Sciences, Inc. Feb 24, 2025 | Compensation for services other than consulting (speaking, faculty) Livdelzi · INFLAM Company’s description;4110497;AHM;10042045 | $3,790 |
| AbbVie Inc. May 8, 2025 | Compensation for services other than consulting (speaking, faculty) MAVYRET · VIROLOGY | $2,875 |
All 45 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| AbbVie Inc. Nov 10, 2025 | Compensation for services other than consulting (speaking, faculty) MAVYRET · VIROLOGY | $2,875 |
| Gilead Sciences, Inc. Oct 24, 2025 | Compensation for services other than consulting (speaking, faculty) Epclusa · HCV Company’s description;4249345;GTF;10042045 | $600 |
| AbbVie Inc. Oct 20, 2025 | Travel and Lodging MAVYRET · VIROLOGY · travel to SPANISH FORK, UT · in-kind | $385 |
| AbbVie Inc. Sep 10, 2025 | Compensation for services other than consulting (speaking, faculty) MAVYRET · VIROLOGY | $2,875 |
| AbbVie Inc. Sep 4, 2025 | Compensation for services other than consulting (speaking, faculty) MAVYRET · VIROLOGY | $1,725 |
| AbbVie Inc. Jul 30, 2025 | Compensation for services other than consulting (speaking, faculty) MAVYRET · VIROLOGY | $4,600 |
| AbbVie Inc. Jul 30, 2025 | Travel and Lodging MAVYRET · VIROLOGY · travel to DENVER, CO · in-kind | $40.00 |
| AbbVie Inc. Jul 14, 2025 | Travel and Lodging MAVYRET · VIROLOGY · travel to OGDEN, UT · in-kind | $61.74 |
| AbbVie Inc. Jul 11, 2025 | Travel and Lodging MAVYRET · VIROLOGY · travel to DENVER, CO · in-kind | $346 |
| AbbVie Inc. Jul 11, 2025 | Travel and Lodging MAVYRET · VIROLOGY · travel to DENVER, CO · in-kind | $285 |
| AbbVie Inc. Jul 11, 2025 | Travel and Lodging MAVYRET · VIROLOGY · travel to DENVER, CO · in-kind | $40.00 |
| AbbVie Inc. Jul 7, 2025 | Compensation for services other than consulting (speaking, faculty) MAVYRET · VIROLOGY | $2,875 |
| Intercept Pharmaceuticals, Inc. Jun 19, 2025 | Travel and Lodging OCALIVA · Hepatology / Gastroenterology · travel to Phoenix, AZ · in-kind | $311 |
| Gilead Sciences, Inc. Jun 10, 2025 | Compensation for services other than consulting (speaking, faculty) Epclusa · HCV Company’s description;4121003;AHM;10042045 | $4,930 |
| Gilead Sciences, Inc. Jun 5, 2025 | Travel and Lodging Epclusa · HCV · travel to Price, UT · in-kind Company’s description;4327682;AHM;10042045 | $890 |
| AbbVie Inc. May 8, 2025 | Compensation for services other than consulting (speaking, faculty) MAVYRET · VIROLOGY | $2,875 |
| Gilead Sciences, Inc. Apr 15, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s description;4128648;AHM;10042045 | $2,370 |
| Gilead Sciences, Inc. Apr 1, 2025 | Compensation for services other than consulting (speaking, faculty) Livdelzi · INFLAM Company’s description;4119486;AHM;10042045 | $4,930 |
| Intercept Pharmaceuticals, Inc. Mar 29, 2025 | Consulting Fee OCALIVA · Hepatology / Gastroenterology | $6,200 |
| Intercept Pharmaceuticals, Inc. Mar 29, 2025 | Travel and Lodging OCALIVA · Hepatology / Gastroenterology · travel to Chicago, IL · in-kind | $824 |
| Intercept Pharmaceuticals, Inc. Mar 29, 2025 | Travel and Lodging OCALIVA · Hepatology / Gastroenterology · travel to Chicago, IL | $80.00 |
| Intercept Pharmaceuticals, Inc. Mar 29, 2025 | Travel and Lodging OCALIVA · Hepatology / Gastroenterology · travel to Chicago, IL · in-kind | $49.00 |
| Intercept Pharmaceuticals, Inc. Mar 29, 2025 | Travel and Lodging OCALIVA · Hepatology / Gastroenterology · travel to Chicago, IL · in-kind | $26.99 |
| Intercept Pharmaceuticals, Inc. Mar 28, 2025 | Travel and Lodging OCALIVA · Hepatology / Gastroenterology · travel to Chicago, IL · in-kind | $307 |
| Intercept Pharmaceuticals, Inc. Mar 28, 2025 | Travel and Lodging OCALIVA · Hepatology / Gastroenterology · travel to Chicago, IL · in-kind | $204 |
| Gilead Sciences, Inc. Mar 26, 2025 | Travel and Lodging Livdelzi · INFLAM · travel to Logan, UT · in-kind Company’s description;4098401;AHM;10042045 | $788 |
| Gilead Sciences, Inc. Mar 4, 2025 | Travel and Lodging Livdelzi · INFLAM · travel to Denver, CO · in-kind Company’s description;4098666;AHM;10042045 | $65.00 |
| Gilead Sciences, Inc. Feb 28, 2025 | Compensation for services other than consulting (speaking, faculty) Livdelzi · INFLAM Company’s description;4124425;AHM;10042045 | $6,440 |
| Gilead Sciences, Inc. Feb 27, 2025 | Travel and Lodging Livdelzi · INFLAM · travel to Denver, CO · in-kind Company’s description;4327848;AHM;10042045 | $791 |
| Gilead Sciences, Inc. Feb 26, 2025 | Travel and Lodging Livdelzi · INFLAM · travel to Denver, CO · in-kind Company’s description;4122857;AHM;10042045 | $142 |
| Gilead Sciences, Inc. Feb 24, 2025 | Compensation for services other than consulting (speaking, faculty) Livdelzi · INFLAM Company’s description;4110497;AHM;10042045 | $3,790 |
| Gilead Sciences, Inc. Feb 24, 2025 | Travel and Lodging Livdelzi · INFLAM · travel to Denver, CO · in-kind Company’s description;4122333;AHM;10042045 | $597 |
| Gilead Sciences, Inc. Feb 22, 2025 | Travel and Lodging Epclusa · HCV · travel to San Diego, CA · in-kind Company’s description;4031109;GTF;10042045 | $697 |
| Gilead Sciences, Inc. Feb 19, 2025 | Travel and Lodging Epclusa · HCV · travel to Las Vegas, NV · in-kind Company’s description;4146817;VEM US;10042045 | $364 |
| Gilead Sciences, Inc. Feb 10, 2025 | Consulting Fee Epclusa · HCV Company’s description;4146792;VEM US;10042045 | $4,760 |
| Gilead Sciences, Inc. Jan 28, 2025 | Travel and Lodging Epclusa · HCV · travel to Las Vegas, NV · in-kind Company’s description;4147391;VEM US;10042045 | $199 |
| Gilead Sciences, Inc. Jan 28, 2025 | Travel and Lodging Epclusa · HCV · travel to Las Vegas, NV · in-kind Company’s description;4149225;VEM US;10042045 | $135 |
| Gilead Sciences, Inc. Jan 28, 2025 | Travel and Lodging Epclusa · HCV · travel to Las Vegas, NV Company’s description;4147394;VEM US;10042045 | $75.00 |
| Gilead Sciences, Inc. Jan 27, 2025 | Travel and Lodging Epclusa · HCV · travel to Las Vegas, NV · in-kind Company’s description;4147383;VEM US;10042045 | $199 |
| Gilead Sciences, Inc. Jan 16, 2025 | Compensation for services other than consulting (speaking, faculty) Livdelzi · INFLAM Company’s description;4112769;AHM;10042045 | $6,440 |
| Gilead Sciences, Inc. Jan 16, 2025 | Compensation for services other than consulting (speaking, faculty) Epclusa · HCV Company’s description;4128075;AHM;10042045 | $3,790 |
| Gilead Sciences, Inc. Jan 15, 2025 | Travel and Lodging Livdelzi · INFLAM · travel to Denver, CO · in-kind Company’s description;4098713;AHM;10042045 | $65.00 |
| Gilead Sciences, Inc. Jan 8, 2025 | Travel and Lodging Livdelzi · INFLAM · travel to Denver, CO · in-kind Company’s description;3956907;AHM;10042045 | $721 |
| Gilead Sciences, Inc. Jan 8, 2025 | Travel and Lodging Livdelzi · INFLAM · travel to Denver, CO · in-kind Company’s description;4113648;AHM;10042045 | $649 |
| Gilead Sciences, Inc. Jan 6, 2025 | Travel and Lodging Livdelzi · INFLAM · travel to Denver, CO · in-kind Company’s description;4327948;AHM;10042045 | $338 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.